Literature DB >> 16917235

Prevention and treatment of osteoporosis in inflammatory bowel disease.

Gary R Lichtenstein1, Bruce E Sands, Michael Pazianas.   

Abstract

The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16917235     DOI： 10.1097/00054725-200608000-00016

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


  23 in total

Review 1.  Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-18       Impact factor: 4.052

Review 2.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

3.  Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System.

Authors:  Nalini Valluru; Le Kang; Jill K J Gaidos
Journal:  Dig Dis Sci       Date:  2018-05-08       Impact factor: 3.199

Review 4.  Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

Authors:  Paul E Evans; Darrell S Pardi
Journal:  MedGenMed       Date:  2007-03-19

5.  Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.

Authors:  Arjuna Priyadarsin de Silva; Aranjan Lionel Karunanayake; Thalahitiya Gamaralalage Iruka Dissanayaka; Anuradha Supun Dassanayake; Hewa Kattadi Kankanamgae Tilak Duminda; Arunasalam Pathmeswaran; Ananda Rajitha Wickramasinghe; Hithanadura Janaka de Silva
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

6.  Old-age inflammatory bowel disease onset: a different problem?

Authors:  Joaquin Hinojosa del Val
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

7.  Increased fracture risk assessed by fracture risk assessment tool in Greek patients with Crohn's disease.

Authors:  Sotirios Terzoudis; Christos Zavos; John Damilakis; John Neratzoulakis; Daphne Anna Dimitriadi; Maria Roussomoustakaki; Elias A Kouroumalis; Ioannis E Koutroubakis
Journal:  Dig Dis Sci       Date:  2012-08-03       Impact factor: 3.199

Review 8.  Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.

Authors:  Geoffrey C Nguyen; Shane M Devlin; Waqqas Afif; Brian Bressler; Steven E Gruchy; Gilaad G Kaplan; Liliana Oliveira; Sophie Plamondon; Cynthia H Seow; Chadwick Williams; Karen Wong; Brian M Yan; Jennifer Jones
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

9.  The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model.

Authors:  Xingtao Ge; Zhijian Chen; Zhenjie Xu; Fang Lv; Kewei Zhang; Yu Yang
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

Review 10.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.